Core Viewpoint - A-share listed companies are increasingly engaging in shareholder return activities, combining "creative" physical gifts with systematic cash dividend plans, reflecting a new trend in the market [1][6]. Group 1: Shareholder Return Activities - Companies like Haoxiangni are offering exclusive purchasing rights for holiday gift boxes at 50% off retail prices, leading to a stock price increase of over 20% since January 8 [1]. - In 2025, over 40 companies are expected to disclose shareholder return or gifting activities, marking a historical high and indicating a growing emphasis on sharing development results with investors [1][2]. - Industries most active in these activities include food and beverage, basic chemicals, pharmaceuticals, and home appliances, with notable companies like Qianwei Yangchun and Northeast Pharmaceutical participating [2]. Group 2: Market Reactions - The market has responded positively to these "creative" gifting activities, with average stock price increases outpacing the CSI 300 index following announcements [3]. - Companies such as Rongtai Health and Emei Mountain A experienced significant stock price surges post-announcement, with Huada Gene seeing a cumulative increase of over 70% within ten trading days [3]. - However, some companies like Bona Film Group and Innotech saw stock price declines after their announcements, indicating that while these activities can boost short-term sentiment, long-term performance will revert to fundamentals [3]. Group 3: Financial Performance and Dividend Plans - Many companies engaging in shareholder returns are showing strong financial performance, with Lianhua Holdings projecting a net profit of 290 million to 330 million yuan in 2025, a year-on-year increase of 43.15% to 62.9% [5]. - Approximately 60% of the 40 companies involved in return activities are expected to see growth or turnaround in 2025, with 90% projected to have net profit growth exceeding 10% in 2026 [5]. - Some companies have established long-term cash dividend plans, with 10 companies committing to distribute at least 10% of their distributable profits over the next three years, signaling a commitment to shareholder returns [6].

Core Viewpoint - A-share listed companies are actively engaging in shareholder return activities, utilizing methods beyond cash dividends, such as offering products, services, discount coupons, or exclusive rights, with mixed market performance but overall outpacing the CSI 300 index [1] Group 1: Shareholder Return Activities - Approximately 130 companies have shown varied market performance, with some adopting creative ways to reward shareholders [1] - Companies are not only providing gifts but are also formulating future dividend plans, with 10 companies announcing shareholder return strategies for the next three years [1] Group 2: Dividend Plans and Performance - The top performers in terms of stock price increase since 2025 include Haoen Qidian (301488) with a rise of 205.66%, Shuiyang Co. (300740) at 87.59%, and Huasheng Co. (600156) at 69.18% [3] - Specific dividend plans include: - Haoen Qidian: Minimum 10% of distributable profit annually from 2025 to 2027 [3] - Shuiyang Co.: Cash dividends not less than 10% of distributable profit annually from 2025 to 2027 [3] - Huasheng Co.: Cumulative cash distribution of at least 30% of the average distributable profit over the last three years from 2026 to 2028 [3] - Other companies like Gais Food (36.36%) and Bona Film (34.26%) also have significant dividend commitments [3]

Core Viewpoint - The article highlights the deceptive practices in the medical beauty industry, particularly the use of "scripted marketing" tactics to manipulate consumers into purchasing high-priced services, ultimately leading to consumer dissatisfaction and potential regulatory scrutiny [1][2]. Group 1: Deceptive Marketing Practices - Medical beauty institutions often employ "scripted marketing" strategies to create a tailored experience for consumers, making them more susceptible to purchasing high-priced projects [1]. - The role of "beauty promoters" (美托) is emphasized, as they are trained to lure consumers into beauty salons and subsequently upsell expensive treatments, often leading to consumer exploitation [2]. - The article describes a specific case where a consumer spent nearly 90,000 yuan over six months with minimal results, illustrating the emotional and financial toll on consumers [2]. Group 2: Regulatory Response - In May 2023, the State Administration for Market Regulation and 11 other departments issued guidelines to strengthen oversight of the medical beauty industry, specifically targeting "beauty promoters" and commercial bribery [2]. - Despite regulatory efforts, the continued presence of "beauty promoters" indicates a need for enhanced regulatory measures to fully understand and address the industry's deceptive practices [2]. Group 3: Industry Implications - The article raises concerns about the long-term sustainability of the medical beauty industry if deceptive practices continue, as consumer trust is eroded when the truth behind these marketing tactics is revealed [2][3]. - The notion of "beautiful economy" is discussed, cautioning against the prevalence of "beauty traps" that could undermine the industry's reputation and future growth [3].

Core Viewpoint - The company, Liaoning He Eye Hospital Group Co., Ltd., is launching a shareholder reward program to express gratitude to its investors and establish a long-term, diverse shareholder return mechanism [1][5]. Group 1: Activity Content - The program includes personalized eye health service consultants for each participating shareholder, offering "full-process convenient services" [1]. - Discounts on optical products such as orthokeratology lenses, myopia management lenses, and frame glasses will be provided [1]. - Exclusive discounts on diagnostic projects including visual training, genetic testing, and meibomian gland massage therapy are part of the offerings [1]. - Shareholders will receive special discounts on myopia correction refractive surgeries [1]. - Aesthetic medical projects will also be included in the rewards [1]. - Customized eye health check-up plans will be available for shareholders [1]. Group 2: Participation Scope - The program is open to current shareholders, historical shareholders, and future investors, including direct relatives (spouse, parents, children) of the shareholders [2]. Group 3: Activity Locations - The activities will take place at the company's subsidiary hospitals and core city clinics [3]. Group 4: Activity Duration - The program will be executed long-term starting from the date of the announcement [4]. Group 5: Participation Method - More details about the activities will be available through the WeChat account "He Eye Investor Relations," with relevant content to be published on December 26, 2025 [5]. Group 6: Additional Notes - This initiative is a practical measure for the company to implement its shareholder return philosophy and express sincere gratitude for the long-term support and attention from shareholders [5].

Core Viewpoint - He Eye Hospital (301103.SZ) is celebrating its 30th anniversary by launching an "Investor Health Feedback Activity" to establish a long-term and diverse shareholder return mechanism, expressing gratitude to shareholders for their ongoing support and trust [1] Group 1: Investor Engagement - The company will provide each participating shareholder with a dedicated eye health service consultant to offer "full-process convenient services" [1] - Discounts will be available on optical products such as orthokeratology lenses, myopia management lenses, and frame glasses [1] - Exclusive discounts on diagnostic projects including eye-brain visual training, genetic testing, and meibomian gland massage therapy will be offered [1] Group 2: Surgical and Aesthetic Services - Shareholders will receive exclusive discounts on myopia correction refractive surgeries [1] - Aesthetic medical projects will also be included in the offerings [1] - Special eye health check-up plans will be available for shareholders [1]

Core Viewpoint - He Eye Hospital (301103.SZ) celebrates its 30th anniversary by launching an "Investor Health Feedback Activity" to establish a long-term and diverse shareholder return mechanism, expressing gratitude to shareholders for their ongoing support and trust [1] Group 1: Investor Engagement - The company provides each participating shareholder with a dedicated eye health service consultant to offer "full-process convenient services" [1] - Discounts on optical products such as orthokeratology lenses, myopia management lenses, and frame glasses are available for shareholders [1] - Exclusive discounts on diagnostic projects including eye-brain visual training, genetic testing, and meibomian gland massage treatment are offered [1] Group 2: Surgical and Aesthetic Services - Shareholders receive exclusive discounts on myopia correction refractive surgeries [1] - Aesthetic medical projects are included in the offerings for shareholders [1] - Special eye health check-up plans are available for participating shareholders [1]

Core Viewpoint - The rise of the beauty economy has led to the popularization of medical aesthetics consumption, but it has also resulted in various industry issues, including price transparency, effectiveness discrepancies, and doubts about institutional qualifications. Consumers are increasingly turning to complaint platforms and understanding merchant reputations to avoid pitfalls before making decisions in the medical aesthetics sector [1][12]. Group 1: Importance of Pre-Complaint Checks - Medical aesthetics consumption is characterized by high professionalism, information asymmetry, high decision costs, and significant associated risks. Problems can lead to irretrievable economic losses and long-term impacts on physical and mental health [2][14]. - Actively checking past complaint records, resolution attitudes, and user evaluations of medical institutions has become a crucial step in risk avoidance [2][14]. Group 2: Official Platforms for Complaint Information - Consumers should focus on credible official platforms that provide reliable data and standardized processing procedures for decision-making [3][15]. - The National 12315 platform, operated by the State Administration for Market Regulation, is a key channel for handling consumer disputes, allowing users to check complaint numbers, resolution rates, and specific complaint details related to medical aesthetics institutions [6][15]. - The Health and Wellness Committee has dedicated complaint channels for medical quality and safety, which can be used to check the violation records of institutions involved in illegal medical practices [6][18]. Group 3: Social Complaint Platforms as Decision Aids - Social complaint platforms, due to their fast information updates and strong interactivity, have become important tools for consumers to avoid pitfalls beforehand [5][17]. - For example, the Black Cat Complaint platform aggregates a large number of user complaints and displays merchants' response attitudes and resolution progress, aiding in assessing service awareness and integrity [5][17]. - Key points to focus on when reviewing complaints include incomplete institutional qualifications, false advertising, price transparency issues, unclear product sources, and difficulties in post-sale rights protection [5][17]. Group 4: Comprehensive Evaluation Using Different Complaint Channels - For high-risk medical aesthetics consumption, a dual-line investigation approach combining official and social channels is recommended [21]. - Steps include checking qualifications through the Health and Wellness Committee's website, searching for complaints on platforms like 12315 and Black Cat Complaint, reviewing user experiences on social media, and consulting individuals with similar experiences [21]. Group 5: Post-Consumption Complaint Channels - If issues arise post-consumption, consumers should promptly utilize various complaint channels, each focusing on different aspects: the Health and Wellness Committee for medical compliance, market regulation departments for commercial behavior, and social platforms for public pressure on merchants [10][22]. - Multiple channels can enhance the efficiency of problem resolution [10][22]. Group 6: Rational Consumption and Active Rights Protection - Medical aesthetics is a unique decision-making process that combines medical and service attributes, making rationality and thorough pre-research essential [23]. - Consumers should view checking complaint information as a responsible action rather than suspicion, and they should choose legitimate institutions, sign clear contracts, and retain all evidence [23][24].

Group 1 - The article highlights the rising consumer interest in "light medical beauty" projects, such as injection and laser treatments, during the summer vacation period, particularly among students [1] - The provincial consumer association advises consumers to verify the qualifications of medical institutions and practitioners before undergoing beauty treatments, emphasizing the importance of checking licenses and registration [1] - There is a warning against the prevalence of "medical beauty loans" and "campus loans," urging consumers to assess their financial capabilities to avoid debt traps [1] Group 2 - In the context of study tours, the provincial consumer association recommends choosing reputable study tour institutions and carefully reviewing contracts in accordance with the newly implemented "Study Tour Service Requirements" [2] - Consumers are encouraged to compare prices of similar study tour products to avoid overpaying and to scrutinize vague promotional claims from institutions [2] - The article stresses the importance of thorough research on training institutions, including evaluating faculty qualifications and course materials, while being cautious of misleading advertising [2]